Lynette Smith, MS

Statistical Coordinator

University of Nebraska Medical Center
College of Public Health

Professional Summary 

• 2000-present  University of Nebraska Medical Center

Education 

• MS  Biostatistics, University of Minnesota, 2000
• BS  Mathematics, University of Nebraska-Lincoln, 1998

Research Interest & Projects

I am interested in the analysis of microarray data and work closely with Dr. Jim Eudy director of the Microarray Core Facility at UNMC. I am also interested in lymphoma research and I am the assistant statistician for the Children’s Oncology Group’s Soft Tissue Sarcoma Biology and Banking Protocol.

Selected Publications

• Fang NY, Greiner TC, Weisenburger DD, Chan WC, Vose JM, Smith LM, Armitage JO, Mayer RA, Pike BL, Collins FS, Hacia JG. Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma. Proc Natl Acad Sci U S A 2003 Apr 29;100(9):5372-7.
• Pavletic SZ, Smith LM, Bishop MR, Lynch JC, Tarantolo SR, Vose JM, Bierman PJ, Hadi A, Armitage JO, Kessinger A. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation. Am J Hematol. 2005 Apr;78(4):265-74.
• Hans CP, Weisenburger DD, Greiner TC, Chan WC, Aoun P, Cochran GT, Pan Z, Smith LM, Lynch JC, Bociek RG, Bierman PH, Vose JM, Armitage JO. Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma. Mod Pathol. 2005 Oct;18(10):1377-84.
• Hock LM, Lynch J, Balaji KC. Increasing Incidence of all Stages of Kidney Cancers over the Last Two Decades in the United States: An Analysis of Surveillance, Epidemiology and End Results Program (SEER) Data. Journal of Urology 2002; 167(1): 57-60.
• Spunt SL, Smith LM, Ruymann FB, Qualman SJ, Donaldson SS, Rodeberg DA, Anderson JR, Crist WM. Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6072-9.

Professional Affiliations

• Children's Oncology Group
• ENAR
• Nebraska Lymphoma Study Group